COVID-19 Update >> We Are Open 24/7
The Product Lawyers Defective Products Lawyers Logo
A National Alliance Of Products Lawyers
Handling Complex Injury Cases
(877) 671-6480

FDA Issues Black Box Warning For Popular Gout Drug Uloric

FDA Black Box Warning Says Uloric Has Increased Risk of Heart-Related Deaths

Following an in-depth study, the U.S. Food and Drug Administration (FDA) issued a black box warning for the gout medicine Uloric in February of 2019. This is the most serious medication warning issued by the FDA, which warns potential users of the drug of the severe adverse effects of the drugs that receive the label.

The FDA study found that Uloric has an increased risk of death when compared to another gout medicine called allopurinol. The administration made this conclusion following a detailed review of safety clinical trial results, which found that Uloric has an increased risk of both heart-related deaths and deaths from all other causes.

Along with the black box warning, the FDA has added a new patient Medication Guide for Uloric. They have also limited the approved use of the drug to patients who have not been treated effectively or have experienced severe side effects with allopurinol.

Learn More: Uloric Lawsuit TV Commercials Discuss Stroke & Heart Attacks Connected to Gout Medication

FDA Recommendations For Uloric Patients

The FDA has suggested that users of Uloric tell their doctor or another healthcare professional if they have a history of heart issues or strokes and discuss the benefits and risks of Uloric as a treatment for gout.

Additionally, they suggest seeking emergency medical care immediately if you have experienced any of the following symptoms while taking Uloric:

  • Sudden and severe headaches
  • Chest pain
  • Rapid or irregular heartbeat
  • Numbness or weakness on one side of the body
  • Dizziness
  • Difficulty speaking
  • Shortness of breath

If you have noticed any of these adverse symptoms, don't stop taking Uloric until you first talk with your healthcare professional. Stopping suddenly can make gout worse.

Potential For Uloric Lawsuits From Sufferers of Cardiovascular Problems

Our defective drug lawyers are currently exploring the potential for Uloric lawsuits against Takeda Pharmaceuticals, the manufacturer of the drug. We specialize in helping families who have been affected by the adverse effects of dangerous drugs find answers, support, and financial compensation for the difficulties they've faced.

If you or someone you love has suffered severe health problems such as a heart attack or stroke while taking Uloric, we are prepared to help your family explore your legal options. You deserve justice for the suffering you've been forced to endure due to the negligence of a pharmaceutical company that placed their own profits above the lives of their customers.

Continue Reading: Former Takeda Pharmaceuticals Safety Consultant Files Whistleblower Lawsuit

  • Contact Info
  • Case Details

Free Case Evaluation

Call Today
24/7 Helpline
Free Consults
Get Justice
(877) 671-6480
Laurence Banville
Date Published: July 10, 2019
Contact Our Consumer Advocates Today
Call Our 24/7 Recalled Products Helpline Now
(877) 671-6480
© 2020 TheProductLawyers.com. All rights reserved.

TheProductLawyers.com is primarily sponsored by Banville Law, PLLC, a New York-based law firm, with attorneys licensed to practice law in the state of New York. and the District of Columbia. TheProductLawyers.com is an alliance of attorneys across the United States who dedicate their professional careers to representing individuals who were seriously injured by defective products, drugs and medical devices. This website is to be considered ATTORNEY ADVERTISING. Past settlement and verdict values are no guarantee of similar future outcomes. TheProductLawyers.com is not a law firm. TheProductsLawyers.com has a team of consumer advocates who can help connect consumers or patients to members of the TheProductLawyers.com alliance who are experienced in a specific type of case for a free legal consultation.

SitemapDisclaimer / Terms Of Service & Privacy Policy